Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Y-mAbs Therapeutics | YMAB | Apr 17, 2024 | 15.11 | -0.20 |
Yalla ADR | YALA | Apr 17, 2024 | 4.63 | -0.64 |
Yatra Online | YTRA | Apr 17, 2024 | 1.40 | -4.11 |
Yatsen ADR | YSG | Apr 17, 2024 | 3.61 | +0.28 |
Yelp | YELP | Apr 17, 2024 | 39.56 | 0.00 |
YETI | YETI | Apr 17, 2024 | 37.03 | -1.80 |
Yext | YEXT | Apr 17, 2024 | 5.57 | +1.27 |
Yield10 Bioscience | YTEN | Apr 17, 2024 | 0.28 | -2.28 |
Yieldshares High Income ETF | YYY | Apr 17, 2024 | 11.57 | +0.57 |
Yiren Digital ADR | YRD | Apr 17, 2024 | 4.71 | -2.08 |
York Water | YORW | Apr 17, 2024 | 33.80 | +1.41 |
Yoshiharu Global A | YOSH | Apr 17, 2024 | 3.92 | +7.99 |
Yoshitsu ADR | TKLF | Apr 17, 2024 | 0.24 | +2.67 |
Yotta Acquisition | YOTA | Apr 17, 2024 | 10.61 | 0.00 |
Yotta Acquisition Unit | YOTAU | Apr 17, 2024 | 9.95 | 0.00 |
Youdao A ADR | DAO | Apr 17, 2024 | 3.76 | -3.09 |
YPF Sociedad Anonima ADR | YPF | Apr 17, 2024 | 19.47 | -3.85 |
YS Biopharma | YS | Apr 17, 2024 | 0.94 | +9.63 |
Yum China | YUMC | Apr 17, 2024 | 36.88 | -0.19 |
Yum! Brands | YUM | Apr 17, 2024 | 137.83 | -0.12 |
Yunhong Green CTI | YHGJ | Apr 17, 2024 | 1.40 | -0.71 |
Yunji ADR | YJ | Apr 17, 2024 | 0.79 | +2.53 |
Zai Lab ADR | ZLAB | Apr 17, 2024 | 13.72 | -4.85 |
Zalatoris II Acquisition | ZLS | Apr 17, 2024 | 10.88 | +0.23 |
Zapata Computing | ZPTA | Apr 17, 2024 | 1.96 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | Apr 17, 2024 | 0.17 | -33.45 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Apr 17, 2024 | 41.59 | +0.55 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Apr 17, 2024 | 55.89 | +0.53 |
Zebra Technologies A | ZBRA | Apr 17, 2024 | 276.14 | -1.52 |
Zedge B | ZDGE | Apr 17, 2024 | 2.35 | -1.67 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.